Search Results - "Paule, B"

The impact of transoesophageal echocardiography in elderly patients with infective endocarditis by N’cho-Mottoh, Marie-Paule B., Erpelding, Marie-Line, Roubaud, Claire, Delahaye, François, Fraisse, Thibaut, Dijos, Marina, Ennezat, Pierre-Vladimir, Fluttaz, Arnaud, Richard, Benjamin, Beaufort, Corinne, Nazeyrollas, Pierre, Brasselet, Camille, Pineau, Olivier, Tattevin, Pierre, Curlier, Elodie, Iung, Bernard, Forestier, Emmanuel, Selton-Suty, Christine

“…[Display omitted] •We compared patients aged > 75 years treated for IE, who did/did not undergo TEE.•Patients without TEE were older, with more…”
Get full text

A proposed new method for assessing the pathological response to chemotherapy in resected colorectal liver metastases by Sebagh, M, Allard, M-A, Cunha, A S, Ruiz, A, Araujo, R, Lemoine, A, Paule, B, Delvart, V, Cherqui, D, Vibert, E, Adam, R

“…Background: Pathological response (PR) to preoperative chemotherapy for colorectal liver metastases (CLM) is recognised as a prognostic factor of outcome…”
Get full text

Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases by Wicherts, D. A., de Haas, R. J., Sebagh, M., Saenz Corrales, E., Gorden, D. L., Lévi, F., Paule, B., Azoulay, D., Castaing, D., Adam, R.

“…Background: The impact of bevacizumab on functional recovery and histology of the liver was evaluated in patients undergoing hepatic resection for colorectal…”
Get full text

Bone mass in young adults with Down syndrome by Guijarro, M., Valero, C., Paule, B., Gonzalez-Macias, J., Riancho, J. A.

“…Background  Down syndrome (DS) is a frequent cause of intellectual disability. With the increasing life expectancy of these patients, concerns have been raised…”
Get full text

Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively by Allard, M A, Adam, R, Ruiz, A, Vibert, E, Paule, B, Levi, F, Sebagh, M, Guettier, C, Azoulay, D, Castaing, D

“…The discovery of unexpected peritoneal carcinomatosis (PC) at the time of hepatectomy for colorectal liver metastases (CLM) is usually considered a…”
Get full text

2095 Survival benefit, safety, and prognostic factors for outcome with Regorafenib (RE) in patients (pts) with pretreated metastatic colorectal cancer (mCRC). Main analyses of the REBECCA study by Fontaniere, C. De La Fouchardiere, Paule, B, Burtin, P, Wallet, J, Tougeron, D, Dourthe, L.M, Etienne, P.L, Mineur, L, Becuwe, C, Maes, P, Dauba, J, Michel, P, Wendling, J.L, Linot, B, Hollebecque, A, Clisant, S, Morere, J.F, Andre, T, Phelip, J.M, Adenis, A

Get full text

2090 Prognostic score (REGOSCORE) for survival after Regorafenib (RE) treatment for patients (pts) with pretreated metastatic colorectal cancer (mCRC) by Kramar, A, Paule, B, Burtin, P, Tougeron, D, Desseigne, F, Dourthe, L.M, Wallet, J, Etienne, PL, Mineur, L, Becuwe, C, Maes, P, Dauba, J, Michel, P, Hollebecque, A, Linot, B, Morere, J.F, Fouchardiere, C. De la, Phelip, J.M, Andre, T, Adenis, A

Get full text

Evaluation of the humoral and cellular immune response to different antigens of Corynebacterium pseudotuberculosis in Canindé goats and their potential protection against caseous lymphadenitis by Moura-Costa, L.F., Bahia, R.C., Carminati, R., Vale, V.L.C., Paule, B.J.A., Portela, R.W., Freire, S.M., Nascimento, I., Schaer, R., Barreto, L.M.S., Meyer, R.

“…Corynebacterium pseudotuberculosis is the etiologic agent of caseous lymphadenitis, a disease that affects goats and sheep, and can cause severe economic…”
Get full text

Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer by Eymard, J-C, Priou, F, Zannetti, A, Ravaud, A, Lepillé, D, Kerbrat, P, Gomez, P, Paule, B, Genet, D, Hérait, P, Ecstein-Fraïssé, E, Joly, F

“…Background: Docetaxel (Taxotere®)-based regimens are the new standard therapy in advanced hormone-refractory prostate cancer (HRPC). A synergistic activity has…”
Get full text

Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density by García-Unzueta, M T, Riancho, J A, Zarrabeitia, M T, Sañudo, C, Berja, A, Valero, C, Pesquera, C, Paule, B, González-Macías, J, Amado, J A

“…The aim of the study was to investigate the distribution of 163 A/G osteoprotegerin gene promoter and 1181 G/C osteoprotegerin exon 1 polymorphisms in a group…”
Get more information

Extended survival following liver resection for breast cancer metastases by Ruiz, A, Sebagh, M, Wicherts, D, Giacchetti, S, Castro-Benitez, C, Linn, S, van Hillegersberg, R, Paule, B, Castaing, D, Morère, J.-F, Adam, R

Get full text

Liver resection for breast cancer metastases by Ruiz, A, Wicherts, D, Sebagh, M, Giacchetti, S, Castro-Benitez, C, Linn, S, van Hillegersberg, R, Paule, B, Castaing, D, Morère, J.-F, Adam, R

Get full text

170 IMPACT OF ADJUVANT CHEMOTHERAPY FOR HEPATOCELLULAR CARCINOMA BEYOND MILAN ON HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION by Mazzola, A, Coilly, A, Delvart, V, Sebagh, M, Roche, B, Roque-Afonso, A.-M, Antonini, T.M, Paule, B, Duclos- Vallee, J.-C, Samuel, D

Get full text

Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? by Allard, M.A, Adam, R, Ruiz, A, Vibert, E, Paule, B, Levi, F, Sebagh, M, Guettier, C, Azoulay, D, Castaing, D

“…Abstract Aims The discovery of unexpected peritoneal carcinomatosis (PC) at the time of hepatectomy for colorectal liver metastases (CLM) is usually considered…”
Get full text

Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysis by Bouchahda, M., Macarulla, T., LIedo, G., Lévi, F., Elez, M. E., Paule, B., Karaboué, A., Artru, P., Tabernero, J., Machover, D., Innominato, P., Goldschmidt, E., Bonnet, D., Ducreux, M., Castagne, V., Guimbaud, R.

“…Cetuximab was approved using a weekly schedule, alone or in combination with chemotherapy (CT). However, many CT regimens in metastatic colorectal cancer (CRC)…”
Get full text

Immunohistochemical variability of epidermal growth factor receptor (EGFR) in liver metastases from colonic carcinomas by Bralet, M-P, Paule, B, Falissard, B, Adam, R, Guettier, C

“…Aims:  To follow and compare immunohistochemical expression of epidermal growth factor receptor (EGFR) in tumour cells during the entire natural history of…”
Get full text

Three-phase partitioning as an efficient method for extraction/concentration of immunoreactive excreted–secreted proteins of Corynebacterium pseudotuberculosis by Paule, B.J.A, Meyer, R, Moura-Costa, L.F, Bahia, R.C, Carminati, R, Regis, L.F, Vale, V.L.C, Freire, S.M, Nascimento, I, Schaer, R, Azevedo, V

“…The three-phase partitioning (TPP) technique was used upstream to isolate/concentrate secreted proteins from Corynebacterium pseudotuberculosis cultured in a…”
Get full text

Serologic immunoreactivity to Neospora caninum antigens in dogs determined by indirect immunofluorescence, western blotting and dot-ELISA by Pinheiro, A.M., Costa, M.F., Paule, B., Vale, V., Ribeiro, M., Nascimento, I., Schaer, R.E., Almeida, M.A.O., Meyer, R., Freire, S.M.

“…Neospora caninum, is a coccidian protozoan known as a major cause of bovine abortion and canine neuropathies. The aim of the present study was to develop a…”
Get full text

Renal medullary carcinoma: remission with gemcitabine-cisplatin and review of therapeutic perspectives by Diao, B, Paule, B, Esquivel, S, Abbou, C C, Salomon, L, De La Taille, A

“…We report a case of renal medullary carcinoma concerning a 38-year-old woman. Heterozygote sickle cell trait was noticed in her past medical history. The…”
Get more information

Pilot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy: results on toxicity, side effects and quality-of-life by Ploussard, G, Paule, B, Salomon, L, Allory, Y, Terry, S, Vordos, D, Hoznek, A, Vacherot, F, Abbou, C-C, Culine, S, de la Taille, A

“…Therapeutic strategy remains unclear with no clear consensus for men with high-risk prostate cancer (PCa) after radical prostatectomy. We aimed to evaluate…”
Get full text